Southampton Research Biorepository (SRB)
The Southampton Research Biorepository (SRB) is funded by the NIHR Clincial Research Facility to provide a local infrastructure within which biological samples can be collected and securely stored, in addition to a regulatory framework and administration system to coordinate delegated NHS research ethics approval. The following types of studies are eligible for application to the SRB for NRES approval: - Studies using tissue samples collected as part of routine NHS care (surplus to diagnosis tissue). - Studies applying for tissues already held within the SRB. Additionally, study teams may apply to the SRB to prospectively collect and house tissues in the SRB for use in future research studies. - Samples collected from patients, acquired for banking for use in future research studies. - Samples collected from healthy participants, acquired for banking for use in future research studies. - Pilot studies and studies from investigators across the University are welcome. For application forms and further advise please contact SRB@uhs.nhs.uk
Existing samples:
- COVID-19
- Fit and well (finding)
- Malignant lymphoma (disorder)
- Severe combined immunodeficiency due to absent interleukin-2 receptor (disorder)
Bespoke collection capabilities:
- COVID-19
Contact Information
- Email:
- SRB@uhs.nhs.uk
- Telephone:
- 02381204989
- Address:
-
NIHR Southampton Clinical Research Facility
University Hospital Southampton NHS Foundation Trust
Southampton General Hospital
Tremona Road
Southampton
Hampshire
SO16 6YD
England
Last Updated: 02/27/2023
Annual Statistics
Year | Access Requests Received | Access Requests Approved | ||||
---|---|---|---|---|---|---|
Internal | External | Commercial | Internal | External | Commercial | |
2015 | N/A | N/A | N/A | N/A | N/A | N/A |
2016 | N/A | N/A | N/A | N/A | N/A | N/A |
2017 | N/A | N/A | N/A | N/A | N/A | N/A |
2018 | N/A | N/A | N/A | N/A | N/A | N/A |
2019 | N/A | N/A | N/A | N/A | N/A | N/A |
2020 | N/A | N/A | N/A | N/A | N/A | N/A |
2021 | N/A | N/A | N/A | N/A | N/A | N/A |
2022 | N/A | N/A | N/A | N/A | N/A | N/A |
2023 | N/A | N/A | N/A | N/A | N/A | N/A |
2024 | N/A | N/A | N/A | N/A | N/A | N/A |